03.03.2013 Views

Best Practice in Outpatient Hysteroscopy - British Society for ...

Best Practice in Outpatient Hysteroscopy - British Society for ...

Best Practice in Outpatient Hysteroscopy - British Society for ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Adequate, clear and simple written patient <strong>in</strong><strong>for</strong>mation should be provided with the<br />

appo<strong>in</strong>tment letter.The <strong>in</strong><strong>for</strong>mation will vary accord<strong>in</strong>g to local circumstances and the type of<br />

service offered. Where simultaneous treatments are offered (‘see and treat’ services), it is<br />

important that this fact is reflected <strong>in</strong> the patient literature to facilitate <strong>in</strong><strong>for</strong>med choice. It is<br />

good cl<strong>in</strong>ical practice to obta<strong>in</strong> <strong>for</strong>mal consent <strong>for</strong> outpatient hysteroscopy be<strong>for</strong>e the<br />

procedure.<strong>Practice</strong> should con<strong>for</strong>m to recommendations on consent from the General Medical<br />

Council and the RCOG.The RCOG has produced ConsentAdvice No.1:Diagnostic hysteroscopy<br />

under general anaesthesia, 22 which should be used <strong>in</strong> conjunction with RCOG Cl<strong>in</strong>ical<br />

Governance Advice No. 6: Obta<strong>in</strong><strong>in</strong>g valid consent. 23 Women should be able to access advice<br />

follow<strong>in</strong>g any <strong>in</strong>tervention (e.g. a direct l<strong>in</strong>e to the cl<strong>in</strong>ic and an out-of-hours contact number).<br />

Consideration should be given to allow direct access <strong>for</strong> GPs accord<strong>in</strong>g to locally developed<br />

criteria and selected groups of women to aid streaml<strong>in</strong><strong>in</strong>g of the service.<br />

5. Analgesia<br />

5.1 Do analgesics given be<strong>for</strong>e diagnostic hysteroscopy reduce the pa<strong>in</strong> felt by women dur<strong>in</strong>g the procedure?<br />

Rout<strong>in</strong>e use of opiate analgesia be<strong>for</strong>e outpatient hysteroscopy should be avoided as<br />

it may cause adverse effects.<br />

Women without contra<strong>in</strong>dications should be advised to consider tak<strong>in</strong>g standard<br />

doses of non-steroidal anti-<strong>in</strong>flammatory agents (NSAIDs) around 1 hour be<strong>for</strong>e their<br />

scheduled outpatient hysteroscopy appo<strong>in</strong>tment with the aim of reduc<strong>in</strong>g pa<strong>in</strong> <strong>in</strong> the<br />

immediate postoperative period.<br />

A systematic review 24 identified six studies which exam<strong>in</strong>e the use of analgesics compared with controls<br />

be<strong>for</strong>e outpatient hysteroscopy. 25–30 All of these studies were randomised controlled trials.Three of the<br />

studies exam<strong>in</strong>ed the use of opiate drugs 25–27 and three exam<strong>in</strong>ed NSAIDs. 28–30<br />

Two of the opiate studies exam<strong>in</strong>ed the use of 100 mg tramadol adm<strong>in</strong>istered approximately 50<br />

m<strong>in</strong>utes be<strong>for</strong>e the outpatient hysteroscopy, one study giv<strong>in</strong>g the tramadol <strong>in</strong>tramuscularly 25<br />

and the second giv<strong>in</strong>g it as an <strong>in</strong>travenous <strong>in</strong>fusion. 26 The first study found that the women who<br />

had received tramadol had significantly less pa<strong>in</strong> at the end of the procedure than women <strong>in</strong> the<br />

<strong>in</strong>tracervical block group and the women who received no medication (P = 0.001 and P < 0.001,<br />

respectively). 25 Although this was a low-quality study, the result was supported by those from<br />

the second, high-quality study which reported significantly lower pa<strong>in</strong> scores <strong>in</strong> the tramadol<br />

group compared with placebo both dur<strong>in</strong>g (P < 0.012) and 15 m<strong>in</strong>utes after (P < 0.008) the<br />

procedure. 26 The third opiate study exam<strong>in</strong>ed the use of subl<strong>in</strong>gual buprenorph<strong>in</strong>e 0.2 mg 40<br />

m<strong>in</strong>utes be<strong>for</strong>e the procedure compared with placebo.There was no significant pa<strong>in</strong> reduction<br />

with the use of buprenorph<strong>in</strong>e overall and when stratified <strong>for</strong> menopausal status and parity. 30<br />

Two studies reported adverse effects. 26,30 The tramadol study found no significant difference<br />

between the groups <strong>in</strong> terms of <strong>in</strong>cidence of nausea, vomit<strong>in</strong>g or bradycardia. 26 Conversely, <strong>in</strong><br />

the buprenorph<strong>in</strong>e study there was a high <strong>in</strong>cidence of adverse effects (nausea, vomit<strong>in</strong>g and<br />

drows<strong>in</strong>ess) <strong>in</strong> the <strong>in</strong>tervention group (38.8%) and none <strong>in</strong> the control group. 30<br />

Three trials exam<strong>in</strong>ed the use of NSAIDs be<strong>for</strong>e outpatient hysteroscopy. 28–30 One of these<br />

studies assessed the use of 50 mg oral diclofenac 1–2 hours be<strong>for</strong>e the procedure and found that<br />

it did not significantly reduce the pa<strong>in</strong> experienced compared with placebo: mean (standard<br />

deviation) <strong>in</strong> the diclofenac group 3.0 (2.5) versus 3.0 (2.9) <strong>in</strong> the control group. 30 Vasovagal<br />

reactions were not reduced <strong>in</strong> the diclofenac group compared with the placebo group (four<br />

reactions and five reactions, respectively). The only adverse effects were <strong>in</strong> the diclofenac<br />

treatment group,but these were mild and self-limit<strong>in</strong>g (one woman reported drug rash and one<br />

compla<strong>in</strong>ed of epigastric pa<strong>in</strong>).The second NSAID study compared the use of 500 mg oral<br />

RCOG Green-top Guidel<strong>in</strong>e No. 59<br />

7 of 22<br />

Evidence<br />

level 4<br />

© Royal College of Obstetricians and Gynaecologists<br />

B<br />

B<br />

Evidence<br />

level 1–<br />

Evidence<br />

level 1–

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!